Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. QQQ

Go back to Genmab and CureVac Enter Strategic Partnership to Develop mRNA-based Antibody Therapeutics
(NASDAQ: GMAB) Delayed: 33.54 +0.13 (0.39%)
Previous Close $33.41    52 Week High $ 
Open $33.36    52 Week Low $ 
Day High $33.98    P/E N/A 
Day Low $33.30    EPS $ 
Volume 1,233,727